1. Home
  2. CADL vs BCAL Comparison

CADL vs BCAL Comparison

Compare CADL & BCAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Candel Therapeutics Inc.

CADL

Candel Therapeutics Inc.

N/A

Current Price

$8.34

Market Cap

641.2M

Sector

Health Care

ML Signal

N/A

Logo Southern California Bancorp

BCAL

Southern California Bancorp

N/A

Current Price

$21.46

Market Cap

704.1M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
CADL
BCAL
Founded
1999
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
641.2M
704.1M
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
CADL
BCAL
Price
$8.34
$21.46
Analyst Decision
Strong Buy
Buy
Analyst Count
10
4
Target Price
$22.11
★ $24.75
AVG Volume (30 Days)
★ 905.6K
186.5K
Earning Date
11-12-2026
10-28-2026
Dividend Yield
N/A
★ 2.24%
EPS Growth
58.62
★ 777.27
EPS
N/A
★ 0.86
Revenue
★ $125,000.00
N/A
Revenue This Year
N/A
$1.22
Revenue Next Year
N/A
$6.66
P/E Ratio
★ N/A
$24.92
Revenue Growth
N/A
N/A
52 Week Low
$4.35
$16.87
52 Week High
$14.00
$22.41

Technical Indicators

Market Signals
Indicator
CADL
BCAL
Relative Strength Index (RSI) 36.89 46.21
Support Level $7.70 $21.17
Resistance Level $9.42 $21.87
Average True Range (ATR) 0.54 0.43
MACD 0.06 -0.03
Stochastic Oscillator 27.27 34.92

Price Performance

Historical Comparison
CADL
BCAL

About CADL Candel Therapeutics Inc.

Candel Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The immune cells induced by these viral immunotherapies are believed to target patients' specific tumor antigens, potentially improving responses in immunologically hot tumors while at the same time infiltrating the tumor microenvironment, transforming non-inflamed cold tumors with limited immune response into hot tumors. The company has established two clinical off-the-shelf viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

About BCAL Southern California Bancorp

California BanCorp is a relationship-focused community bank offering commercial loan and deposit products, along with other services delivered directly or through strategic alliances, to business and individual customers in its target markets. The Company provides financial products and services to individuals, professionals, and small to medium-sized businesses through its branch and commercial banking offices serving California. Its lending products consist mainly of construction and land development loans, real estate loans, C&I loans, and consumer loans, and it is a Preferred SBA Lender, while its deposit products consist mainly of demand deposit, money market, and certificates of deposit. The Company operates in one reportable segment, commercial banking.

Share on Social Networks: